Salts of phosphatidylinositol 3-kinase inhibitor compound
PK201000515A0Undetermined Publication Date: 2010-07-01NOVARTIS AG
0 Cites 0 Cited by
Patent Information
- Application Number
- PK201000515
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2010-06-14
- Publication Date
- 2010-07-01
Abstract
Pharmaceutical acceptable salt of phosphatidylinositol (PI) 3- kinase inhibitor compound , composition, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and use of the new compound, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative disease characterized by the abnormal activity of growth factors, protein serine / threonine kinases, and phospholipid kinases.
Need to check novelty before this filing date? Find Prior Art